Evaluation of treatment and survival after positive second-look laparotomy
Authors:
- Mark F. SchrayMSMark F. Schray
- Harry S. WieandHWHarry S. Wieand
- John H. EdmonsonJEJohn H. Edmonson
- John A. JefferiesJJJohn A. Jefferies
- Harry J. LongHLHarry J. Long
- George D. MalkasianGMGeorge D. Malkasian
- C.RObert StanhopeCSC.RObert Stanhope
- Timothy O. WilsonTWTimothy O. Wilson
- 1 September 1988
- journal article
- Published by Elsevier in Gynecologic Oncology
- Vol. 31 (1) , 9-21
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Etoposide (VP-16-213) plus cis-diamminedichloroplatinum as salvage therapy in advanced epithelial ovarian cancerGynecologic Oncology, 1987
- Salvage therapy with whole-abdominal irradiation in patients with advanced carcinoma of the ovary previously treated by combination chemotherapyCancer, 1986
- A review of second-look laparotomy for ovarian cancerGynecologic Oncology, 1986
- Recurrent ovarian carcinoma: Retreatment utilizing combination chemotherapy including cis-diamminedichloroplatinum in patients previously responding to this agentGynecologic Oncology, 1985
- Second-look laparotomy in ovarian cancer: Evaluation of pathologic variablesAmerican Journal of Obstetrics and Gynecology, 1985
- Cisplatin, methotrexate, and 5-fluorouracil combination chemotherapy for advanced ovarian cancerGynecologic Oncology, 1985
- Microscopic disease at second-look laparotomy in advanced ovarian cancerCancer, 1985
- A prospective randomized clinical trial of melphalan and cis-platinum versus hexamethylmelamine, adriamycin, and cyclophosphamide in advanced ovarian cancerGynecologic Oncology, 1983
- Second-look operations in ovarian cancerAmerican Journal of Obstetrics and Gynecology, 1980
- Second trial drugs in ovarian cancerGynecologic Oncology, 1977